CRA International, Inc. (CRAI) Price Target Analysis
Updated Jun 18, 2026
Analyst Rating: Buy
Based on 1 analysts39.9% Below Target
CRAI trades 39.9% below Wall Street's consensus target of $194.00.
Current Price$138.70
Average Target$194.00
Low$194.00
Median$194.00
High$194.00
Analyst Target Range
Forward P/E16.8x
(Fair)
PEG Ratio0.78
(Undervalued)
Implied Growth+13.3%
(Moderate)
Analyst Spread0.0%
(High Agreement)
Price Forecast (1 Year)
Last 12 months price action with 12-month analyst target path
Consensus Scenario Assumptions
The base valuation assumes CRAI achieves its forward estimates and maintains a stable P/E multiple of 16.8x. This scenario reflects the blended consensus of 1 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
CRAI Price Target Analysis
Updated June 22, 2026As of June 22, 2026, CRA International, Inc. (CRAI) has a Wall Street consensus price target of $194.00, based on estimates from 1 covering analysts. With the stock currently trading at $138.70, this represents a potential upside of +39.9%. The company has a market capitalization of $896M.
Analyst price targets range from a low of $194.00 to a high of $194.00, representing a 0% spread in expectations. The median target of $194.00 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Buy, with 1 analysts rating the stock as a Buy or Strong Buy,0 rating it Hold, and 0 rating it Sell or Strong Sell. This overwhelmingly bullish sentiment suggests analysts see significant catalysts for upside ahead.
From a valuation perspective, CRAI trades at a trailing P/E of 17.0x and forward P/E of 16.8x. The forward PEG ratio of 0.78 suggests the stock may be undervalued relative to its growth. Analysts expect EPS to grow +13.3% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $178.43, with bear and bull scenarios of $112.41 and $235.10 respectively. Model confidence stands at 51/100, reflecting moderate uncertainty in projections.
Investment Context: Price targets represent analyst expectations for the next 12 months and should be considered alongside your own research. Targets are based on analysts' assumptions about earnings growth, margins, and market conditions which may change. For sector-specific context, view other Industrials stocks.
Analyst Sentiment Comparison
Industry Peer AnalysisAvg Peer Upside
+46.6%
Industry Consensus
Avg Forward P/E
17.0x
(Fair)
Peers with Coverage
9 / 10
Active Analyst Tracking
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
 HURNHuron Consulting Group Inc. | $1.5B | $90.56 | $157.50 | +73.9% | Buy | 10.2x | 9 |
 FTITechnipFMC plc | $26.1B | $65.17 | $71.14 | +9.2% | Buy | 22.0x | 50 |
 EXPOExponent, Inc. | $2.8B | $56.89 | $75.00 | +31.8% | Buy | 27.7x | 8 |
 FORRForrester Research, Inc. | $128M | $6.70 | — | — | Hold | 8.8x | 4 |
 ICFIICF International, Inc. | $1.2B | $66.51 | $90.00 | +35.3% | Buy | 9.5x | 13 |
 MCOMoody's Corporation | $79.9B | $450.67 | $541.31 | +20.1% | Buy | 27.0x | 32 |
 VRSKVerisk Analytics, Inc. | $22.8B | $173.80 | $226.11 | +30.1% | Hold | 22.7x | 25 |
 CSGPCoStar Group, Inc. | $12.8B | $30.12 | $61.18 | +103.1% | Buy | 22.1x | 25 |
 ACNAccenture plc | $80.3B | $130.54 | $236.31 | +81.0% | Buy | 9.4x | 53 |
 BAHBooz Allen Hamilton Holding Corporation | $7.9B | $66.36 | $89.50 | +34.9% | Buy | 10.9x | 21 |
CRAI — Frequently Asked Questions
Quick answers to the most common questions about buying CRAI stock.
What is the CRAI stock price target for 2026?
The consensus Wall Street price target for CRAI is $194, representing 39.9% upside from the current price of $138.7. With 1 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.
Is CRAI a buy, sell, or hold?
CRAI has a consensus rating of "Buy" based on 1 Wall Street analysts. The rating breakdown is predominantly bullish, with 1 Buy/Strong Buy ratings. The consensus 12-month price target of $194 implies 39.9% upside from current levels.
Is CRAI stock overvalued or undervalued?
With a forward P/E of 16.8301x, CRAI trades at a relatively low valuation. The consensus target of $194 implies 39.9% appreciation, suggesting meaningful undervaluation.
How high can CRAI stock go?
The most bullish Wall Street analyst has a price target of $194 for CRAI, while the most conservative target is $194. The consensus of $194 represents the median expectation. Our quantitative valuation model projects a bull case target of $235 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
How many analysts cover CRAI stock?
CRAI is lightly followed, with 1 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 1 have Buy ratings, 0 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
What is the CRAI stock forecast?
The 12-month CRAI stock forecast based on 1 Wall Street analysts shows a consensus price target of $194, with estimates ranging from $194 (bear case) to $194 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $178, with bear/bull scenarios of $112/$235.
What is CRAI's fair value based on fundamentals?
Our quantitative valuation model calculates CRAI's fair value at $178 (base case), with a bear case of $112 and bull case of $235. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 51/100.
What is CRAI's forward P/E ratio?
CRAI trades at a forward P/E ratio of 16.8x based on next-twelve-months earnings estimates compared to a trailing P/E of 17.0x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Should I buy CRAI stock?
Wall Street analysts are very optimistic on CRAI, with a "Buy" consensus rating and $194 price target (39.9% upside). 1 of 1 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
Why do CRAI price targets vary so much?
CRAI analyst price targets range from $194 to $194, a 0% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $194 consensus represents the middle ground. Our model's $112-$235 range provides an independent fundamental perspective.
Consensus-Based Analysis Tools
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Check Valuation
Historical Returns
10-year return with dividends reinvested.
Calculate
DCA Calculator
See how regular investing compounds over time.
Run Numbers
Peer Comparison
Compare growth, multiples, and margins vs sector.
Compare